Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
A new brain cancer study is testing an ultrasound technology developed at Columbia to determine if the technology can open the blood-brain barrier and improve delivery of chemotherapy.
Even a brief exposure to addictive medications for surgery-related pain or anxiety can lead to long-term use, a study by Columbia researchers has found.
New guidelines encourage initial screening for colorectal cancer at 45 instead of 50, because younger people are increasingly being diagnosed with the disease, says Columbia's James Church, MD.
Opinions vary about how to treat DCIS (ductal carcinoma in situ), but a new study suggests the optimal treatment for most women with this non-invasive breast cancer is surgery plus radiation.
Results from a phase 2 clinical trial led by Columbia cancer researchers suggest that a combination of two drugs has potential to improve treatment of uterine leiomyosarcoma.
Larisa Geskin's first lobbying success led New York state to prohibit indoor tanning for children. Now she's urging Medicaid to help low-income families access sunscreen.
Many women and their physicians stick to annual Pap and HPV tests, Columbia researchers have found, despite new guidelines recommending less frequent cervical cancer screening.
Columbia cancer researchers are testing a new chemotherapy regimen for patients with an invasive form of bladder cancer who have limited options beyond radical surgery if initial treatment fails.
Newly identified immune cells infiltrate tumors in patients with localized kidney cancer and may be driving the cancer’s recurrence, Columbia researchers have found.